Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.
Puppo M, Valluru MK, Croset M, Ceresa D, Iuliani M, Khan A, Wicinski J, Charafe-Jauffret E, Ginestier C, Pantano F, Ottewell PD, Clézardin P. Puppo M, et al. Among authors: iuliani m. Br J Cancer. 2023 Sep;129(5):754-771. doi: 10.1038/s41416-023-02340-9. Epub 2023 Jul 13. Br J Cancer. 2023. PMID: 37443350 Free PMC article.
New targets, new drugs for metastatic bone pain: a new philosophy.
Pantano F, Zoccoli A, Iuliani M, Lanzetta G, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: iuliani m. Expert Opin Emerg Drugs. 2011 Sep;16(3):403-5. doi: 10.1517/14728214.2011.588600. Epub 2011 May 31. Expert Opin Emerg Drugs. 2011. PMID: 21623686
Premetastatic niche: ready for new therapeutic interventions?
Zoccoli A, Iuliani M, Pantano F, Imperatori M, Intagliata S, Vincenzi B, Marchetti P, Papapietro N, Denaro V, Tonini G, Santini D. Zoccoli A, et al. Among authors: iuliani m. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S119-29. doi: 10.1517/14728222.2012.656092. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443277 Review.
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.
Vincenzi B, Zoccoli A, Schiavon G, Iuliani M, Pantano F, Dell'aquila E, Ratta R, Muda AO, Perrone G, Brunelli C, Correale P, Riva E, Russo A, Loupakis F, Falcone A, Santini D, Tonini G. Vincenzi B, et al. Among authors: iuliani m. Eur J Cancer. 2013 Apr;49(6):1501-8. doi: 10.1016/j.ejca.2012.11.014. Epub 2012 Dec 22. Eur J Cancer. 2013. PMID: 23266047 Free article.
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.
Santini D, Zoccoli A, Gregorj C, Di Cerbo M, Iuliani M, Pantano F, Zamarchi R, Sergi F, Flammia G, Buscarini M, Rizzo S, Cicero G, Russo A, Vincenzi B, Avvisati G, Tonini G. Santini D, et al. Among authors: iuliani m. Oncology. 2013;85(6):342-7. doi: 10.1159/000347226. Epub 2013 Dec 3. Oncology. 2013. PMID: 24335337 Clinical Trial.
MicroRNAs and bone metastasis: a new challenge.
Croset M, Santini D, Iuliani M, Fioramonti M, Zoccoli A, Vincenzi B, Tonini G, Pantano F. Croset M, et al. Among authors: iuliani m. Molecules. 2014 Jul 11;19(7):10115-28. doi: 10.3390/molecules190710115. Molecules. 2014. PMID: 25019555 Free PMC article. Review.
Deregulation of dicer and mir-155 expression in liposarcoma.
Vincenzi B, Iuliani M, Zoccoli A, Pantano F, Fioramonti M, De Lisi D, Frezza AM, Rabitti C, Perrone G, Onetti Muda A, Russo A, Giordano A, Santini D, Dei Tos AP, Tonini G. Vincenzi B, et al. Among authors: iuliani m. Oncotarget. 2015 Apr 30;6(12):10586-91. doi: 10.18632/oncotarget.3201. Oncotarget. 2015. PMID: 25888631 Free PMC article.
Emerging drugs for the treatment of bone metastasis.
Pantano F, Iuliani M, Zoccoli A, Fioramonti M, De Lisi D, Fioroni I, Ribelli G, Santoni M, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: iuliani m. Expert Opin Emerg Drugs. 2015;20(4):637-51. doi: 10.1517/14728214.2015.1062876. Epub 2015 Jun 25. Expert Opin Emerg Drugs. 2015. PMID: 26113304 Review.
44 results